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Abstract
Background: The capability of human mesenchymal stem cells (hMSC) derived of adult bone
marrow to undergo in vitro hepatic differentiation was investigated.
Results: Exposure of hMSC to a cocktail of hepatogenic factors [(fibroblast growth factor-4 (FGF-
4), hepatocyte growth factor (HGF), insulin-transferrin-sodium-selenite (ITS) and dexamethasone)]
failed to induce hepatic differentiation. Sequential exposure to these factors (FGF-4, followed by
HGF, followed by HGF+ITS+dexamethasone), however, resembling the order of secretion during
liver embryogenesis, induced both glycogen-storage and cytokeratin (CK)18 expression. Additional
exposure of the cells to trichostatin A (TSA) considerably improved endodermal differentiation, as
evidenced by acquisition of an epithelial morphology, chronological expression of hepatic proteins,
including hepatocyte-nuclear factor (HNF)-3β, alpha-fetoprotein (AFP), CK18, albumin (ALB),
HNF1α, multidrug resistance-associated protein (MRP)2 and CCAAT-enhancer binding protein
(C/EBP)α, and functional maturation, i.e. upregulated ALB secretion, urea production and inducible
cytochrome P450 (CYP)-dependent activity.
Conclusion: hMSC are able to undergo mesenchymal-to-epithelial transition. TSA is hereby
essential to promote differentiation of hMSC towards functional hepatocyte-like cells.
Background
The ever-increasing number of new chemical entities
(NCEs) has prompted the development of research meth-
ods for rapid screening. Present research efforts are there-
fore directed at developing a series of in vitro assays that
could be applied for preclinical screening of NCEs. By uti-
lizing in vitro models, pharmaceutical companies attempt
to reduce clinical failure rates by accurately evaluating effi-
cacy and safety much earlier in the drug discovery process
[1]. As the liver is the principal organ for xenobiotic
biotransformation and thus a key target for drug-induced
toxicity, in vitro models to predict drug metabolism are
preferably derived from human liver tissues. However, the
use of human hepatocytes is limited by scarcity of intact
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and fresh human liver tissue [2,3]. In addition, primary
hepatocyte cultures still cope with a progressive occur-
rence of dedifferentiation, resulting in a relative short life-
span and a rapid decline of liver-specific functions [4-7].
Different alternatives have been explored to overcome
these difficulties, including the use of human stem cells.
In vivo as well as in vitro studies have provided evidence
that stem cells can overcome germ lineage restrictions and
express molecular characteristics of cells of different tissue
origin [8,9].
The best characterized stem cell compartment is the bone
marrow consisting of two stem cell populations, referred
to as the hematopoietic and mesenchymal stem cells [9].
The latter was first described by Friedenstein et al. as a
population of cells isolated from the bone marrow and
capable of differentiation into bone, adipocytes, chondro-
cytes, osteoblasts, osteoprogenitors, skeletal myocytes,
tendon and bone marrow stromal cells [10,11].
Schwartz  et al. described a novel population of cells
within postnatal rat bone marrow, named multipotent
adult progenitor cells (MAPC), that were not only capable
to differentiate into most mesodermal cell types, but also
into functional neuroectodermal and endodermal (hepa-
tocytes) cell types [12].
In the present study, we investigated whether hMSC also
have the potential to differentiate in vitro into functional
hepatocytes. Therefore, hMSC were cultivated in the pres-
ence of 'hepatogenic' factors, added either as a cocktail
(FGF-4, HGF, ITS and dexamethasone) or, more innova-
tive, in a sequential manner closely reflecting their tempo-
ral expression during in vivo hepatogenesis (FGF-4,
followed by HGF, followed by a combination of HGF, ITS
and dexamethasone). Next, giving the promising differen-
tiation-inducing properties of histone deaceylase inhibi-
tors (HDAC-I) in primary cultures of adult hepatocytes
[13-16] and hepatoma cell lines [17-19], we additionally
examined the effect of TSA, a potent and specific
hydroxamic acid-based HDAC-I, on hMSC cultures.
Results
Characterization of culture-expanded hMSC
hMSC were cultivated from the mononuclear cell fraction
of bone marrow samples obtained from healthy donors.
To ensure removal of contaminating hematopoietic cells,
cells were selected, based on plastic adherence, and pas-
saged 4 times prior to further use.
To ascertain that the culture-expanded cells were genuine
MSC, both their phenotype and mesodermal differentia-
tion potential upon exposure to mesenchymal-supportive
conditions, i.e. chondrogenic, osteogenic and adipogenic-
specific agents, were examined (Fig. 1). Immunopheno-
typic analysis revealed expression of CD73, CD90, CD105
and CD166 and no expression of CD34 and CD45 (Fig.
1). Von Kossa and Oil-Red O staining confirmed the pres-
ence of calcium deposits, characteristic for osteogenic
cells, and lipid droplets, respectively. Immunohistological
staining for collagen type II verified chondrogenic differ-
entiation (Fig. 2). In summary, these results indicate that
the expanded cells have the basic properties of genuine
MSC.
Differentiation of hMSC under 'hepatogenic-supporting' 
conditions
To evaluate whether hMSC could differentiate into endo-
dermal cells, as described earlier for MAPC [12], cells were
exposed to hepatogenic agents, either as a cocktail [12] or
in a sequential manner [20], and analyzed by means of
microscopic analysis and specific cytological stainings.
Optimization of culture conditions
A prerequisite for differentiation in vitro is cell cycle arrest.
In preliminary experiments, we found that, in the pres-
ence of cytokines and growth factors, a non-proliferative
status is only obtained at 100% confluence. Therefore, the
latter cell density was further applied in all differentiation
experiments.
Endogenic differentiation upon sequential exposure of hMSC to 
hepatogenic factors
In contrast to MAPC [12], hMSC did not gain typical mor-
phologic and phenotypic characteristics of hepatocytes
upon exposure to a cocktail of hepatogenic factors. On the
opposite, sequential treatment of hMSC with FGF-4, HGF,
ITS and dexamethasone in a time-dependent order closely
reflecting their secretion pattern during in vivo liver ontog-
eny ('sequential condition') resulted in upregulation of
glycogen uptake from day 8 onwards (Fig. 3A). From days
8–9 onwards, cells also expressed CK18 (Fig. 3B), a
cytoskeletal filament present in hepatocytes. The mor-
phology of the differentiated cells, however, did not
resemble hepatocytes.
TSA, a trigger for functional maturation of endogenic 
differentiating hMSC
In an attempt to enhance endogenic differentiation of
hMSC, TSA, a selective and reversible HDAC-I [13-19],
was added to the culture media in a concentration of 1 μM
after exposure of the cells to the hepatogenic factors.
Optimization of culture conditions
Besides the state of growth arrest, 'time' is often critical for
successful 'trans'differentiation of (progenitor/stem) cells
in epigenetic regulating processes [21]. More specifically,
promotion of 'trans'differentiation into a specific lineage
by means of HDAC inhibition often requires selective pre-
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searched for the most optimal differentiation conditions.
Hereto, we examined the effect of the hepatic inducing
effects of (1) FGF-4, HGF, ITS and dexamethasone, added
alone and in different combinations (e.g. FGF-4, HGF/
HGF, ITS/HGF, dexamethasone/ITS, dexamethasone/ITS,
HGF etc.), and (2) pre- and post-treated with the HDAC
inhibitor TSA. Out of the results obtained, we found that
1 μM TSA, when added exclusively to MSC at 100% con-
fluence and without pretreatment with FGF-4 and HGF,
was not effective in stimulating mesenchymal-to-hepatic
transition. The same applies when these cells were treated
with FGF-4 and HGF afterwards (data not shown). In
addition, treatment of undifferentiated hMSC with 1 μM
TSA resulted in massive cell death and cell detachment
(data not shown). Suppression of proliferation, in parallel
with cell survival and long-term cultivation, were only
obtained upon pre-stimulation of the cells with hepa-
togenic factors for at least 6 days prior to addition of 1 μM
TSA (see Additional files 1, 2, 3). In spite of the good long-
term cell survival, about 20% of the TSA-treated cells
Immunophenotypic analysis of culture-expanded hMSC Figure 1
Immunophenotypic analysis of culture-expanded hMSC. Flow cytometry analysis was performed for CD34, CD45, CD90, CD105, 
CD166 and CD73. The results shown are representative for 5 independent experiments.
Mesodermal differentiation potency of culture-expanded hMSC Figure 2
Mesodermal differentiation potency of culture-expanded hMSC. Characterization of culture-expanded hMSC upon exposure to spe-
cific (A) chondrogenic, (B) osteogenic and (C) adipogenic agents, respectively. Chondrogenic, adipogenic and osteogenic differ-
entiation potential were confirmed by means of (A) immunohistochemical staining of collagen type II fibers, (B) Von Kossa and 
(C) Oil Red O staining, respectively. 64 × 10 original magnification. Stainings shown are representative for at least 5 separate 
experiments.BMC Developmental Biology 2007, 7:24 http://www.biomedcentral.com/1471-213X/7/24
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underwent apoptosis (see Additional file 3). In the
present study, the most appropriate conditions for
transdifferentiation comprised exposure of hMSC to 1 μM
TSA, starting on the 6th day of exposure to hepatogenic
cytokines and growth factors; these treatments are fur-
ther referred to as 'cocktail TSA' and 'sequential TSA'
conditions.
Morphological features
Interestingly, upon exposure to 1 μM TSA, added from day
6 on to differentiating hMSC, cells in about 25% of all
bone marrow samples tested underwent a drastic mor-
phological change, regardless of the culture condition
used (Fig. 4). After 3–5 days, both sequential TSA- and
cocktail TSA-treated hMSC formed epithelioid cells with a
clear round nucleus. Fibroblastic cells, however, persisted
throughout the culture time, particularly upon exposure
to the cocktail TSA-condition (Fig. 4), whereas a more
homogeneous cell population was obtained in the
sequential TSA set-up.
Liver-specific protein expression
To evaluate whether these morphological changes were
associated with enhanced differentiation towards hepato-
cyte-like cells, analysis of early (HNF3β, AFP), mid-late
(ALB, CK18) and late (HNF1α, MRP2 and C/EBPα)
hepatic markers was performed at the protein level. In
fact, sequentially TSA-exposed cells progressively reached
an adult expression pattern: next to CK18 (57 ± 8% on day
9), cells also stained positive for HNF3β (76 ± 2% on day
7), AFP (77 ± 4% on day 7), ALB (87 ± 2% on day 8),
HNF1α (79 ± 1% on day 13), MRP2 (78 ± 1% on day 17)
and C/EBPα (50 ± 3% on day 19) and this in a specific
chronological order (Fig. 5). In line with the results at the
morphological level, cocktail TSA-treatment supported
hepatic differentiation only to a limited extent. More spe-
cifically, throughout the whole culture time, cells failed to
express HNF1α and C/EBPα, both late liver-enriched tran-
scription factors. Also, the major hepatic drug transporter
MRP2 was not expressed (Fig. 5).
Hepatic functionality
To evaluate whether these hepatocyte-like cells derived
from adult human bone marrow also acquired typical
functional hepatic features, ALB secretion, ammonia
metabolism and inducible CYP-dependent activity were
next analysed.
ALB secretion
1 μM TSA, added to sequentially-treated hMSC from day
6 onwards (sequential TSA-condition), significantly
upregulated the ALB secretion rate from day 15 onwards
(p < 0.01, Oneway Anova and Student's t-test) when com-
pared with regular sequential cultures (Fig. 6). A limited
upregulation of the ALB secretion was also detected upon
cocktail TSA-exposure. The raise, however, was not signif-
icant and less distinctive than observed after sequential
Differentiation potential of hMSC upon sequential exposure to hepatogenic agents Figure 3
Differentiation potential of hMSC upon sequential exposure to hepatogenic agents. Upregulated (A) glycogen storage and (B) CK18 
expression was shown by means of PAS-staining and immunofluorescence, respectively. A: 10 × 10 original magnification; B: 32 
× 10 original magnification. Stainings shown are representative for at least 5 separate experiments.
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TSA-treatment. hMSC cultivated without TSA did not
secrete ALB (Fig. 6).
Ureogenesis
Upon sequential TSA-exposure, the urea production
increased in a time-dependent manner, reaching similar
levels as measured in 4 hours-cultured adult hepatocytes
after 24–27 days differentiation (Fig. 7). Cocktail TSA-
exposed hMSC could also synthesize urea; however levels
remained stable and were, even at peak production, signif-
icantly lower (i.e. 29%) (p < 0.01; Student t-test) than the
sequential TSA condition (Fig. 7). In contrast, sequentially
and cocktail-exposed cells, cultivated without TSA, did
not metabolize ammonia (data not shown).
CYP-dependent activity and inducibility
Sequentially-exposed hMSC expressed functionally active
CYP2B6 (Fig. 8). In contrast, no CYP-dependent activity
could be measured upon cocktail-treatment. Additional
exposure to 1 μM TSA significantly promoted the metab-
olising capacity of CYP2B6 and CYP1A1/2 from days 18
and 21 onwards, respectively, regardless of the experimen-
tal set-up (p < 0.05; Student's t-test) (Figs. 8, 9). By day 21,
ethoxyresorufin-O-deethylase (EROD)-activity even
increased towards levels measured in 4 hours-cultivated
primary hepatocytes (Fig. 9). Comparable to the results
obtained for ALB and urea secretion, throughout the cul-
ture time, the metabolising capacity of sequential TSA-
treated cells exceeded that of cocktail TSA-exposed cells
(Figs. 6, 7, 8, 9).
The potential to induce CYP-dependent monooxygenases
is considered as one of the most representative functional
parameters to evaluate the adult hepatic phenotype
[22,23]. Therefore, the responsiveness of both CYP1A1/2
and CYP2B6 to their respective prototype inducers 3-
methylcholantrene (MC) and phenobarbital (PB) was
studied in parallel. Interestingly, only TSA-treated cells
exhibited inducible CYP-activities (Figs. 8, 9). More spe-
cifically, upon TSA-treatment pentoxyresorufin-O-dealky-
lase (PROD)-activities were significantly induced up to
2.2 fold after 3 days exposure to PB (i.e. on day 21),
regardless of the experimental configuration (p < 0.05;
Student's t-test). The inducibility persisted throughout the
culture time (Fig. 8). In addition, a significant 6.4 fold
CYP1A1/2-dependent response to MC was observed on
Cell morphology Figure 4
Cell morphology. Light-microscopic analysis of 17-day old sequentially (+/-1 μM TSA) and cocktail (+/-1 μM TSA)-exposed 
hMSC; 20 × 10 original magnification, phase contrast.
cocktail sequential
- TSA
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Characterization of hepatic differentiation of sequentially TSA- and cocktail TSA-exposed hMSC Figure 5
Characterization of hepatic differentiation of sequentially TSA- and cocktail TSA-exposed hMSC. Immunofluorescence was performed 
for HNF3β-cy3, AFP-FITC, ALB-FITC, CK18-FITC, HNF1α-cy3, MRP2-cy3 and C/EBPα-cy3; 32 × 10 original magnification. 
Stainings shown are representative for at least 4 separate experiments.
HNF3b,D7
AFP,D7
ALB,D8
CK18,D9
HNF1a,D13
MRP2,D17
C/EBPa,D19
Cocktail TSA Sequential TSABMC Developmental Biology 2007, 7:24 http://www.biomedcentral.com/1471-213X/7/24
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days 24–27 in the sequential TSA-model (p < 0.05; Stu-
dent's t-test). Cocktail TSA-treated cells also showed
inducible EROD-activity, but to a significantly lesser
extent (p < 0.001, Student's t test) (Fig. 9).
An overview of all experiments performed along with
their outcome per condition is summarized in table 1.
TSA causes accumulation of acetylated histone H4
The question, however, still remains whether the
improved hepatic differentiation of hMSC, upon exposure
to 1 μM TSA, is mediated by TSA-induced HDAC inhibi-
tion. Since histone H4 is a known target of TSA (21), the
acetylated status of this protein was analysed by means of
immunofluorescence.
Histone H4 was indeed clearly hyperacetylated in both
the cocktail TSA and sequential TSA set-up when com-
pared to the appropriate controls(Fig. 10). Affecting the
acetylated status of histone proteins could thus be pro-
posed here to regulate cell fate.
Discussion
Hepatocyte-based in vitro models are often-used tools for
pharmaco-toxicological research and could also become
an interesting tool for regulatory testing of xenobiotics
[1]. A serious drawback, however, is the occurrence of cel-
lular dedifferentiation [5-7] and the shortage of cells of
human origin. The use of stem cells could offer a solution.
It is well recognized that in adult mammals, including
humans, a number of tissues are continuously regenerated
from immature cells (i.e. skin, intestinal epithelia, blood,
the olfactory bulb in the brain) [8-12,24,25]. The interest
in adult stem cells has in particular been triggered by the
numerous ethical dilemmas surrounding the use of
embryonic stem cells in preclinical and clinical research
[26]. Consequently, successful isolation, cultivation and
manipulation of multipotent stem cells from non-embry-
ALB secretion into the medium was measured by ELISA Figure 6
ALB secretion into the medium was measured by ELISA. hMSC were differentiated in sequential (+/-1 μM TSA) and cocktail (+/-1 
μM TSA) conditions. The results shown are representative for 5 independent experiments. **, ***: ALB-secretion of hMSC cul-
tivated in the sequential TSA-condition is significantly upregulated during culture time, p < 0.01 and p < 0.001 (Student's t-test). 
°°, °°°: ALB-secretion of hMSC cultivated in the sequential TSA-condition is significantly higher than in the sequential set-up, p 
< 0.01 and p < 0.001 (Student's t-test).
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onic origin could provide researchers with an unlimited
human cell source for cell and organ development studies,
preclinical pharmaco-toxicological research and regula-
tory testing.
In the current study, we investigated the in vitro endoder-
mal potency of hMSC. hMSC were hereto exposed to well-
defined hepatogenic agents, added either as a cocktail
('cocktail condition') or, more innovative, in a sequential
time-dependent order as seen during liver embryogenesis
('sequential condition').
Exposure of hMSC to a cocktail of hepatogenic factors
failed to induce mesenchymal-to-epithelial transition. In
contrast, sequential treatment with these hepatogenic
agents ('sequential condition') not only induced expres-
sion of the mid-late hepatic marker CK18 from day 8
onwards but also resulted in hepatic functionality, as evi-
denced by upregulated glycogen storage from days 8 to 22
Urea production in sequentially TSA- and cocktail TSA-exposed hMSC Figure 7
Urea production in sequentially TSA- and cocktail TSA-exposed hMSC. Gray area represents urea levels, produced by 4 hours-cul-
tured adult hepatocytes. The graph is representative for 4 separate experiments, each performed in duplicate. **: Urea produc-
tion significantly differs among sequentially TSA- and cocktail TSA-exposed hMSC with p < 0.01 (Student's t-test).
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Table 1: Summary of all characterization experiments performed along with their outcome.
SEQUENTIAL COCKTAIL SEQUENTIAL TSA COCKTAIL TSA
ENDOGENIC 
DIFFERENTIATION
Cytological staining
PAS ++ - NT NT
Immunofluorescence
AFP, HNF3β, ALB, CK18, 
HNF1α, C/EBPα, MRP2
- - +++ ++
Functional analysis
ALB secretion - - +++ ++
Ureogenesis - - +++ ++
EROD activity - - +++ ++
Inducible EROD activity - - +++ ++
PROD activity + - +++ ++
Inducible PROD activity - - +++ ++
(-): negative; (+),(++),(+++): weak positive, positive, strong positive, respectively; NT: not tested.BMC Developmental Biology 2007, 7:24 http://www.biomedcentral.com/1471-213X/7/24
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and acquisition of CYP2B6-activity, though not inducible,
from day 21 onwards. However, cells did not morpholog-
ically resemble adult hepatocytes.
As a trigger for further differentiation of hMSC towards
the endodermal lineage, TSA, known as a proliferation-
inhibiting and differentiation-inducing agent in primary
hepatocytes and hepatoma cell lines [14-19], was intro-
duced into the present culture media. Previously, our
group showed that exposure of 1 μM TSA to primary cul-
tured hepatocytes induced cell cycle arrest during G0/G1
and G1/S phase in EGF-stimulated cells, significantly
retarded apoptosis and improved cell junction intercellu-
lar communication and xenobiotic biotransformation
[13-16,27,28]. These findings encouraged us to expose
differentiating hMSC to TSA as well. In fact, upon addi-
tion of TSA, hMSC of 1/4 of the bone marrow samples
tested, underwent a mesenchymal-to-hepatic transition.
More specifically, differentiating TSA-exposed cells
adopted an epithelial morphology, expressed liver-spe-
cific proteins and acquired functional maturation, regard-
less of the experimental set-up, although to a different
degree. A rather homogeneous population of epithelioid
cells was obtained upon sequential TSA-treatment. About
70% of these differentiated cells expressed early (HNF3β,
AFP), mid-late (ALB, CK18) and late (HNF1α, MRP2 and
C/EBPα) hepatocyte markers in a ranking order compara-
ble to their expression pattern during in vivo hepatogene-
sis. Indeed, AFP expression is first detected in embryonic
endoderm around E8.5 [29] and precedes ALB, HNF1α
and MRP2 expression, detected around E9.5, E10.5 and
E16, respectively [30-32].
Furthermore, hepatic metabolic functions, including ALB
secretion, urea production, and inducible CYP-activity,
were manifested exclusively in TSA-treated cells and most
prominently under the sequential TSA-conditions. More
specifically, TSA significantly upregulated ALB secretion,
urea synthesis and CYP1A1/2-activities to levels compara-
ble to those found in 4 hours- to 2 days-old monolayer
cultures of adult hepatocytes [15]. In line with the behav-
iour of adult hepatocytes, both in vitro and  in vivo,
responses to the prototype inducers MC and PB were pro-
nounced and discrete, respectively; however, levels of
PROD-activities and responsiveness to 1 mM PB in sequentially (+/-1 μM TSA) or cocktail (+/-1 μM TSA)-exposed hMSC Figure 8
PROD-activities and responsiveness to 1 mM PB in sequentially (+/-1 μM TSA) or cocktail (+/-1 μM TSA)-exposed hMSC. PB was added 
daily, starting on day 18. The graph is representative for 5 separate experiments, each, performed in duplicate. PB, phenobarbi-
tal. *: PROD-activity of sequentially TSA- and cocktail TSA-exposed hMSC is significantly higher than of sequentially- and cock-
tail-exposed hMSC with p < 0.05 (Student's t-test). $,$$: PB significantly induced PROD-activity of sequentially TSA- and 
cocktail TSA-exposed hMSC with p < 0.05 and p < 0.01, respectively (Student's t-test).
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induction, measured in the bone marrow-derived hepato-
cyte-like cells remained lower than in true adult hepato-
cytes.
On the other hand, cocktail TSA-treated cells also featured
hepatic phenotype and function, but less differentiated,
which corresponds well to the persistence of processes
throughout the culture time.
Recently, the hepatic differentiation potential of MSC,
derived from bone marrow, adipose tissue and umbilical
cord blood, has been affirmed by showing expression of
distinct hepatocyte markers and functions, including ALB
and urea secretion, glycogen storage and LDL uptake,
upon in vitro conditioning (i.e. exposure to hepatogenic
agents) of the cells [33-41]. In contrast to our findings, a
functional hepatic phenotype was generally not seen
before 3.5–4 weeks post-stimulation. In addition, no
inducible CYP-dependent activity was reported, which is
considered to be a key determinant of the functional
hepatic phenotype, and a prerequisite for applicability of
the cells as in vitro models for preclinical drug testing.
Only one study described inducible Cyp2B6 expression at
both the mRNA and protein-level [34] but not before 4 to
6 weeks preconditioning of the cells [34]. In contrast, our
TSA-exposed cells already possessed PROD (CYP2B6)-
dependent activity and -inducibility upon 21 days differ-
entiation.
In line with our results, Seo et al., 2005 showed enhanced
hepatic differentiation upon addition of 0.1% dimethyl-
sulfoxide (DMSO) to human adipose tissue-derived stro-
mal cells (hADSC), prestimulated for 10 days with a
cocktail of hepatogenic cytokines [33]. The mechanism
underlying the hepatic (trans)differentiation-inducing
effects of DMSO have not yet been fully elucidated. How-
ever, like TSA, histone hyperacetylation-inducing effects
have been ascribed to DMSO as well [42].
EROD-activities and responsiveness to 2 μM MC in sequentially (+/-1 μM TSA) or cocktail (+/-1 μM TSA)-exposed hMSC Figure 9
EROD-activities and responsiveness to 2 μM MC in sequentially (+/-1 μM TSA) or cocktail (+/-1 μM TSA)-exposed hMSC. MC was 
added daily, starting on day 18. Gray area represents EROD-activity measured in 4 hours-cultured adult hepatocytes, not 
treated with TSA. The graph is representative for 5 separate experiments, each performed in duplicate. MC, 3-methylcholant-
rene. *, **: EROD-activity of sequentially TSA- and cocktail TSA-exposed hMSC is significantly higher than of sequentially- and 
cocktail-exposed hMSC with p < 0.05 and p < 0.01, respectively (Student's t-test). $,$$: MC significantly induced EROD-activity 
of sequentially TSA- and cocktail TSA-exposed hMSC with p < 0.05 and p < 0.01, respectively(Student's t-test). °°°: CYP1A1/2-
inducibility significantly differs among sequentially TSA- and cocktail TSA-exposed hMSC with p < 0.001 (Student's t-test).
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Other research groups showed hepatic differentation of
hMSC upon stimulation to hepatogenic cytokines exclu-
sively, added either as a mixture [FGF-4+HGF [35,36],
separately [HGF [40]; HGF followed by oncostatin M
(OSM) [34,37] or as a combination thereof [FGF+HGF
followed by OSM [41]]. Conform to our experience, the
results shown by Lange et al., 2005 disagreed with those
reports [38]. The reasons underlying these controversial
results are unknown. However, part might be ascribed to
subtle differences in hMSC isolation/expansion tech-
niques, and microenvironment (growth factors,
cytokines, medium additives, cell-cell/cell-matrix contact,
etc.), playing a decisive role in the specific and directed
differentiation of stem/progenitor cells. Additionally, it
should be taken into consideration that the plasticity of
stem/progenitor cells highly depends on the tissue harvest
site and the donor's profile (age, gender, body mass index,
lifestyle, drug intake, etc.). The differentiating potential of
bone marrow-derived MSC, in fact, decreases with age
[43]. In our study, most bone marrow samples were har-
vested from elderly patients, which might also form a part
of the answer. In addition, the hepatic differentiation effi-
ciency of all bone marrow samples tested in the present
study yielded 25%, postulating influence of donor-related
variability as well. The elucidation of all factors involved
seems thus of primary importance and will be explored in
future experiments.
Conclusion
The developmental process of hepatocytes towards a fully
polarized and functional phenotype is known to depend
on a complex network of transcriptional and posttran-
scriptional regulatory events. To our best knowledge, the
results presented in this paper (patent submission PCT-
EP2004-0012134) are the first to indicate that HDAC
inhibition is, next to acquiring and maintaining differen-
tiated functions in primary cells and cell lines, a key-factor
to differentiate bone marrow-derived hMSC into func-
tional hepatocyte-like cells, particularly under sequential
culture conditions mimicking in vivo hepatogenesis.
Long-term cultivation and successful transdifferentiation
of hMSC could be shown under both set-ups (sequential
TSA and cocktail TSA), though a relatively high number
(about 20%) of TSA-treated cells died, due to apoptosis. A
feasible explanation could be that TSA, accompanied by
hepatogenic agents, promotes selective survival of differ-
entiating cells towards the hepatocyte lineage by inducing
apoptosis of non- (hepatic) differentiating cells.
The established model opens new perspectives: it offers an
unlimited source of functional human hepatocyte-like
cells of non-embryonic origin, applicable in basic research
(developmental endoderm biology), preclinical drug dis-
covery and development, and cell and organ design. It
TSA-induced HDAC inhibition Figure 10
TSA-induced HDAC inhibition. Acetylated status of histone H4 in sequentially (+/-1 μM TSA) and cocktail (+/-1 μM TSA)-treated 
hMSC; 32 × 10 original magnification. Differentiation potential of bone-marrow-derived hMSC under sequential-, sequential TSA-, cock-
tail- and cocktail TSA-conditions.
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might open a road for 'trans'-differentiation of cell types
from different tissues towards endodermal lineages. In
addition, as a consequence of their extensive self-renew-
ing capacity, these cells may, in future, overcome the
shortage of human donor tissue contributing as such to
tissue regeneration in congenital and degenerative disor-
ders.
Methods
Expansion of hMSC
Bone marrow samples were aspirated from the sternum of
healthy (male and female) donors with variable age (35–
85 years old), following informed consent. Bone marrow
mononucleated cells were isolated by Ficoll-Hypaque
(Nycomed, Lucron Bioproducts, De Pinte, Belgium) den-
sity-gradient centrifugation and plated in Mesenchymal
Stem Cell Growth Medium (MSCGM, Cambrex, Verviers,
Belgium) at 37°C and under 5%CO2 and 95%air After 4
hours, medium was renewed to remove non-adherent
cells. At 50% confluency, cells were detached with trypsin
(0.05% w/v)/EDTA (0.02% w/v) (Cambrex). Cells were
cultured for 4 passages and finally harvested for further
experiments.
Characterization of culture-expanded hMSC
Immunophenotypic analysis
Cells were labeled with CD34-FITC [Becton Dickinson
(BD), Erembodegem, Belgium], CD45-PE (DAKO),
CD105-FITC (Ancell-10P's, Zandhoven, Belgium), CD73-
PE, CD90-PE, CD166-PE (all from PharMingen, BD) and
analyzed using a flow cytometer (Coulter Epics® XL-MCL,
Analis, Namur, Belgium).
Routine analysis of mesodermal potency
Cells were cultivated in specific media for adipogenic,
osteogenic and chrondrogenic differentiation according
to the manufacturer's instructions (Cambrex). Mesoder-
mal differentiation was verified by means of different
stainings (described below). To exclude spontaneous dif-
ferentiation, hMSC were cultivated in regular MSCGM
medium (Cambrex) and analyzed in parallel.
Endodermal (hepatocyte) differentiation of hMSC
hMSC were plated at 21.5 103 cells/cm2 on 1 mg/ml colla-
gen gel type I (BD) in basal medium supplemented with
2% (v/v) foetal bovine serum (Hyclone, Perbio Science,
Erembodegem, Belgium). Basal medium consisted of
60% (v/v) DMEM and 40% (v/v) MCDB-201 (Invitrogen,
Merelbeke, Belgium) supplemented with 100 IE/ml peni-
cillin (Continental Pharma, Diegem, Belgium), 100 μg/
ml streptomycin, 1 mg/ml linoleic-acid bovine serum
albumin, 0.1 mM L-ascorbic acid, 0.03 mM nicotinamide,
0.25 mM sodium pyruvate and 1.623 mM glutamine (all
from Sigma, Bornem, Belgium). At 100% confluence, cells
were exposed to hepatogenic cytokines and growth fac-
tors, added either simultaneous as a cocktail ('referred to
as 'cocktail-condition/-set-up/-exposure' or a derivative
thereof) [basal medium + 10 ng/ml FGF-4, 20 ng/ml HGF
(all from R&D Systems, Minneapolis, USA), 1 × ITS and
20 μg/l dexamethasone (all from Sigma)] or sequentially
('referred to as 'sequential-condition/-set-up/-exposure' or
a derivative thereof) (days 0–2: basal medium + 10 ng/ml
FGF-4; days 3–5: basal medium + 20 ng/ml HGF; from
day 6 on: basal medium + 20 ng/ml HGF + 1 × ITS and 20
μg/l dexamethasone). Differentiation media were
changed every 3 days. From day 6 onwards, 1 μM TSA
(Sigma) was added. The cocktail- and sequential-condi-
tions, supplemented with 1 μM TSA will be further
referred to as 'cocktail TSA-condition/-set-up/-exposure',
and 'sequential TSA condition/-set-up/-exposure, respec-
tively, or a derivative hereof.
Staining
Cytological staining
Cells were fixed with 10% (w/v) formalin (PolySciences,
Omnilabo International N.V. Aartselaar, Belgium) for 10
min at room temperature (adipogenic, hepatocyte differ-
entiation) or with methanol (Merck, Overijse, Belgium)
for 2 min at -20°C (osteogenic differentiation). After fixa-
tion, adipocytes were identified as red-colored lipid drop-
lets upon staining with Oil-red O (from Sigma) [24].
Mineralized nodules or calcium deposits in differentiated
osteogenic cells were stained black with the von Kossa
technique [24]. Periodic-acid-Schiff (PAS) staining was
used to determine glycogen storage, a functional parame-
ter of endogenic differentiation [12]. As a control, PAS
staining was performed in the presence of amyloglucosi-
dase (Sigma).
Immunohistochemical staining
Chondrocytic differentiation was determined using rabbit
polyclonal anti-collagen II antibody (NCL-COLL-IIp,
NovoCastra, Prosan, Merelbeke, Belgium).
Immunofluorescence
Cells were fixed either with ethanol (Merck) for 10 min at
-20°C (cytoskeletal proteins) or with 4% (w/v) parafor-
maldehyde (Electron Microscopy Sciences, Fort Washing-
ton, PA) for 10 min at 4°C (nuclear and cytoplasmic
markers). After fixation, liver-specific protein expression
was analysed using primary antibodies against AFP (goat),
(HNF3β (goat), HNF1α (rabbit), C/EBPα (rabbit), MRP2
(goat; all from Santa Cruz, Heidelberg, Germany), CK18
(mouse, FITC-conjugated; Sigma) and ALB (goat, FITC-
conjugated; Bethyl Laboratories Montgomery, TX). HDAC
inhibition was assessed using anti-acetyl histone H4 anti-
body (rabbit, Upstate Biotechnology, NY, USA). Respec-
tive secondary antibodies came from Jackson
Immunoresearch, Cambridgeshire, UK. As a negative con-
trol, cells were incubated with appropriate gamma immu-BMC Developmental Biology 2007, 7:24 http://www.biomedcentral.com/1471-213X/7/24
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noglobulines (Jackson Immunoresearch) and
immunostained under the same conditions. Cells were
analysed using fluorescence microscopy with a Zeiss Axio-
vert scope.
Microscopic analysis
Cell morphology was analysed using phase-contrast light-
microscopy (Nikon).
Albumin ELISA
ALB concentrations, secreted into the culture media, were
analysed by ELISA [44].
Urea assay
Urea concentrations produced, after 24 hours-exposure of
the cells to 6 mM NH4Cl (Sigma), were measured colom-
etrically in the culture media according to the manufac-
turer's instructions (Quantichrom Urea assay kit, Bioassay
Systems, Brussels, Belgium). Fresh culture media supple-
mented with 6 mM NH4Cl (Sigma) and 4 hours-cultured
adult hepatocytes were used as negative and positive con-
trols, respectively.
Alkoxyresorufin-O-dealkylase assay
EROD- and PROD-activities were assessed as previously
described [45] with some minor modifications: in our set-
up, cells were incubated with 20 μM 7-ethoxyresorufin
and 18 μM 7-pentoxyresorufin (all from Sigma) for 3
hours and subsequently for 30 min with β-glucuronidase/
arylsulfatase (Roche Applied Science, Vilvoorde, Bel-
gium).
To evaluate the inducibility of CYP2B6 and CYP1A1/2,
cells were, after 18 days of differentiation, exposed to PB
(final concentration 1 mM) and MC (final concentration
2 μM; all from Sigma), respectively. Media, supplemented
with either PB or MC, were daily renewed. Fresh culture
media and 4 hours-cultured adult hepatocytes were used
as negative and positive controls, respectively.
Statistics
Results are expressed as mean ± SD. Statistical analyses
were performed using Oneway Anova and Student's t-test.
The significance level was set at 0.05.
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